Name
Knowledge and Agility: Pivoting in Response to Federal and State Health Policy Changes
Date & Time
Wednesday, April 4, 2018, 9:45 AM - 11:00 AM
Speakers
Kelly Clark, MD, MBA, DFAPA, DFASAM, Chief Medical Officer, Clean Slate Centers, President, American Society of Addiction Medicine, and Member, National Rx Drug Abuse & Heroin Summit Advisory Board
Kimberly Moser, RN, BSN, State Representative, Kentucky, 64th District
Michael Barnes, JD, Chairman, Center for Lawful Access and Abuse Deterrence, and Member, National Rx Drug Abuse & Heroin Summit Advisory Board
Kimberly Moser, RN, BSN, State Representative, Kentucky, 64th District
Michael Barnes, JD, Chairman, Center for Lawful Access and Abuse Deterrence, and Member, National Rx Drug Abuse & Heroin Summit Advisory Board
Description
Moderator: Michael Barnes, JD, Chairman, Center for Lawful Access and Abuse Deterrence, and Member, National Rx Drug Abuse & Heroin Summit Advisory Board
CE Certified By: AMA,AAFP,ACPE,ADA,ANCC,APA,GA Bar,NAADAC,NASW,NBCC
Rx Summit participants are squarely in the middle of two of the nation’s top policy issues: healthcare reform and reducing drug overdoses. Naturally, we must do our best to share our real-world recommendations with policymakers in a way that reflects practical and political realities. We must also prepare to adjust to new laws, regulations and enforcement efforts that may not be all that we had hoped.
This session will address the impact that healthcare reform and overdose reduction policies can have on healthcare providers, patients, prevention leaders, and the public at large. The speakers — a physician, a legislator, and an attorney, all of whom work daily to improve healthcare policy — will discuss current legislative, regulatory, and enforcement initiatives, and analyze their potential impacts on communities. They will provide an inclusive, matter-of-fact overview of how health and safety leaders can respond to contingencies, whether we live in red or blue states.
This session’s topics will be drawn from some of the most timely federal and state health policy debates, and will likely include the following:
- Healthcare reform, including state insurance marketplaces;
- Private insurance and Medicaid coverage of treatment;
- Federal block grants;
- State treatment guidelines for pain and addiction; and
- Law enforcement and prosecutions.
To account for the practical and political realities of making policy in 2018, the presenters’ analyses and recommendations will encompass commonly debated concerns, such as budget, the roles of government and the private sector, and privacy.
UPON COMPLETION OF THIS COURSE, PARTICIPANTS WILL BE ABLE TO:
- Identify two national issues that could have major impacts on efforts to reduce substance use, addiction and overdoses.
- Recognize current legislative, regulatory and enforcement initiatives that could affect substance use prevention and treatment efforts.
- Formulate potential responses to policy changes.
CE Certified By: AMA,AAFP,ACPE,ADA,ANCC,APA,GA Bar,NAADAC,NASW,NBCC
Rx Summit participants are squarely in the middle of two of the nation’s top policy issues: healthcare reform and reducing drug overdoses. Naturally, we must do our best to share our real-world recommendations with policymakers in a way that reflects practical and political realities. We must also prepare to adjust to new laws, regulations and enforcement efforts that may not be all that we had hoped.
This session will address the impact that healthcare reform and overdose reduction policies can have on healthcare providers, patients, prevention leaders, and the public at large. The speakers — a physician, a legislator, and an attorney, all of whom work daily to improve healthcare policy — will discuss current legislative, regulatory, and enforcement initiatives, and analyze their potential impacts on communities. They will provide an inclusive, matter-of-fact overview of how health and safety leaders can respond to contingencies, whether we live in red or blue states.
This session’s topics will be drawn from some of the most timely federal and state health policy debates, and will likely include the following:
- Healthcare reform, including state insurance marketplaces;
- Private insurance and Medicaid coverage of treatment;
- Federal block grants;
- State treatment guidelines for pain and addiction; and
- Law enforcement and prosecutions.
To account for the practical and political realities of making policy in 2018, the presenters’ analyses and recommendations will encompass commonly debated concerns, such as budget, the roles of government and the private sector, and privacy.
UPON COMPLETION OF THIS COURSE, PARTICIPANTS WILL BE ABLE TO:
- Identify two national issues that could have major impacts on efforts to reduce substance use, addiction and overdoses.
- Recognize current legislative, regulatory and enforcement initiatives that could affect substance use prevention and treatment efforts.
- Formulate potential responses to policy changes.